326 related articles for article (PubMed ID: 27920181)
21. Recent development in the strategies projected for chikungunya vaccine in humans.
Goyal M; Chauhan A; Goyal V; Jaiswal N; Singh S; Singh M
Drug Des Devel Ther; 2018; 12():4195-4206. PubMed ID: 30573950
[TBL] [Abstract][Full Text] [Related]
22. Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus.
Cao L; Wang W; Sun W; Zhang J; Han J; Xie C; Ha Z; Xie Y; Zhang H; Jin N; Lu H
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016401
[TBL] [Abstract][Full Text] [Related]
23. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641
[TBL] [Abstract][Full Text] [Related]
24. A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.
Prow NA; Liu L; Nakayama E; Cooper TH; Yan K; Eldi P; Hazlewood JE; Tang B; Le TT; Setoh YX; Khromykh AA; Hobson-Peters J; Diener KR; Howley PM; Hayball JD; Suhrbier A
Nat Commun; 2018 Mar; 9(1):1230. PubMed ID: 29581442
[TBL] [Abstract][Full Text] [Related]
25. A measles virus-based vaccine induces robust chikungunya virus-specific CD4
Schmitz KS; Comvalius AD; Nieuwkoop NJ; Geers D; Weiskopf D; Ramsauer K; Sette A; Tschismarov R; de Vries RD; de Swart RL
Vaccine; 2023 Oct; 41(43):6495-6504. PubMed ID: 37726181
[TBL] [Abstract][Full Text] [Related]
26. Therapeutics and vaccines against chikungunya virus.
Ahola T; Couderc T; Ng LF; Hallengärd D; Powers A; Lecuit M; Esteban M; Merits A; Roques P; Liljeström P
Vector Borne Zoonotic Dis; 2015 Apr; 15(4):250-7. PubMed ID: 25897811
[TBL] [Abstract][Full Text] [Related]
27. Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.
Salazar-González JA; Angulo C; Rosales-Mendoza S
Vaccine; 2015 Jul; 33(31):3650-8. PubMed ID: 26073010
[TBL] [Abstract][Full Text] [Related]
28. Prime-boost immunization strategies against Chikungunya virus.
Hallengärd D; Lum FM; Kümmerer BM; Lulla A; Lulla V; García-Arriaza J; Fazakerley JK; Roques P; Le Grand R; Merits A; Ng LF; Esteban M; Liljeström P
J Virol; 2014 Nov; 88(22):13333-43. PubMed ID: 25210177
[TBL] [Abstract][Full Text] [Related]
29. Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.
Broeckel RM; Haese N; Ando T; Dmitriev I; Kreklywich CN; Powers J; Denton M; Smith P; Morrison TE; Heise M; DeFilippis V; Messaoudi I; Curiel DT; Streblow DN
Front Immunol; 2019; 10():2563. PubMed ID: 31736977
[TBL] [Abstract][Full Text] [Related]
30. Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence.
Lorente E; Barriga A; Barnea E; Palomo C; García-Arriaza J; Mir C; Esteban M; Admon A; López D
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007547. PubMed ID: 31276466
[TBL] [Abstract][Full Text] [Related]
31. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.
Hallengärd D; Kakoulidou M; Lulla A; Kümmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljeström P
J Virol; 2014 Mar; 88(5):2858-66. PubMed ID: 24371047
[TBL] [Abstract][Full Text] [Related]
32. A chikungunya fever vaccine utilizing an insect-specific virus platform.
Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
[TBL] [Abstract][Full Text] [Related]
33. Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.
van den Doel P; Volz A; Roose JM; Sewbalaksing VD; Pijlman GP; van Middelkoop I; Duiverman V; van de Wetering E; Sutter G; Osterhaus AD; Martina BE
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3101. PubMed ID: 25188230
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Kumar M; Sudeep AB; Arankalle VA
Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
[TBL] [Abstract][Full Text] [Related]
35. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
[TBL] [Abstract][Full Text] [Related]
36. Live-attenuated CHIKV vaccine with rearranged genome replicates in vitro and induces immune response in mice.
Tretyakova I; Joh J; Gearon M; Kraenzle J; Goedeker S; Pignataro A; Alejandro B; Lukashevich IS; Chung D; Pushko P
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012120. PubMed ID: 38648230
[TBL] [Abstract][Full Text] [Related]
37. Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.
Powers JM; Haese NN; Denton M; Ando T; Kreklywich C; Bonin K; Streblow CE; Kreklywich N; Smith P; Broeckel R; DeFilippis V; Morrison TE; Heise MT; Streblow DN
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009308. PubMed ID: 33793555
[TBL] [Abstract][Full Text] [Related]
38. Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate.
Chan YH; Teo TH; Utt A; Tan JJ; Amrun SN; Abu Bakar F; Yee WX; Becht E; Lee CY; Lee B; Rajarethinam R; Newell E; Merits A; Carissimo G; Lum FM; Ng LF
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31015278
[TBL] [Abstract][Full Text] [Related]
39. Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice.
Zhao Z; Deng Y; Niu P; Song J; Wang W; Du Y; Huang B; Wang W; Zhang L; Zhao P; Tan W
Front Immunol; 2021; 12():655743. PubMed ID: 33868299
[TBL] [Abstract][Full Text] [Related]
40. A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis.
Wang D; Suhrbier A; Penn-Nicholson A; Woraratanadharm J; Gardner J; Luo M; Le TT; Anraku I; Sakalian M; Einfeld D; Dong JY
Vaccine; 2011 Mar; 29(15):2803-9. PubMed ID: 21320541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
